PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.61%
Revenue growth at 50-75% of 9843.T's 8.68%. Martin Whitman would worry about competitiveness or product relevance.
7.07%
Gross profit growth at 50-75% of 9843.T's 9.51%. Martin Whitman would question if cost structure or brand is lagging.
23.00%
EBIT growth above 1.5x 9843.T's 10.20%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
18.46%
Operating income growth above 1.5x 9843.T's 2.72%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
42.27%
Net income growth above 1.5x 9843.T's 14.87%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
42.25%
EPS growth above 1.5x 9843.T's 14.87%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
42.25%
Diluted EPS growth above 1.5x 9843.T's 14.87%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 9843.T is at 0.16%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 9843.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
22.22%
Dividend growth of 22.22% while 9843.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.40%
10Y revenue/share CAGR at 50-75% of 9843.T's 114.05%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
61.06%
5Y revenue/share CAGR 1.25-1.5x 9843.T's 49.90%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
34.47%
3Y revenue/share CAGR 1.25-1.5x 9843.T's 27.42%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
155.91%
Net income/share CAGR at 50-75% of 9843.T's 223.45%. Martin Whitman might question if the firm’s product or cost base lags behind.
137.88%
5Y net income/share CAGR above 1.5x 9843.T's 53.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
84.91%
3Y net income/share CAGR above 1.5x 9843.T's 33.79%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
215.84%
10Y equity/share CAGR at 75-90% of 9843.T's 277.95%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
132.15%
5Y equity/share CAGR 1.25-1.5x 9843.T's 97.43%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
65.78%
3Y equity/share CAGR 1.25-1.5x 9843.T's 48.99%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-8.33%
Cut dividends over 10 years while 9843.T stands at 300.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-8.33%
Negative 5Y dividend/share CAGR while 9843.T stands at 81.82%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
57.14%
3Y dividend/share CAGR at 75-90% of 9843.T's 66.67%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
34.92%
Our AR growth while 9843.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.59%
Inventory shrinking or stable vs. 9843.T's 12.31%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
5.03%
Similar asset growth to 9843.T's 4.64%. Walter Schloss finds parallel expansions or investment rates.
4.95%
BV/share growth above 1.5x 9843.T's 2.95%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-45.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.